Latest Global Expansion News

Truscreen Group has issued nearly 150 million new shares at NZ$0.013 each, expanding its share base by 17.4% following a renounceable rights issue. The fully paid shares rank equally with existing stock, lifting total ordinary shares to just over one billion.

Cooks Coffee lifted UK and Ireland store sales 22.8% to NZ$95.8 million in FY26, with EBITDA up 14% to NZ$1.39 million. Despite operational growth and debt reduction, net liabilities and liquidity pressures raise material going concern doubts.

TruScreen Group has completed a substantially oversubscribed NZ$2.9 million rights issue, boosting total capital raised to over NZ$4 million. The funds are set to support the company’s global expansion in cervical screening technology.

Control Bionics has locked in $9.5 million through a discounted share placement, complemented by a $0.5 million Share Purchase Plan, to back its commercial growth and technology development.

Memphasys has rapidly established a foothold in the UK IVF market, securing four active commercial trials and initial orders for its Felix™ sperm selection system within weeks of launch. This momentum aligns with its global expansion strategy targeting major fertility markets.

Schoolblazer Group has consolidated its fragmented debt into a $110 million multi-currency facility with Westpac, providing significant headroom for growth and lowering its cost of debt.

AFT Pharmaceuticals surged 22% to NZ$254.7 million revenue in FY26, surpassing profit guidance and securing FDA approval to advance a pivotal injectable iron Phase III trial targeting a $7.4 billion market. The company is poised for further global expansion and product launches in FY27.

AoFrio Limited has successfully closed a renounceable pro-rata rights issue, securing NZ$4.428 million to fund its push into US and European markets and advance AI-driven innovations in cold drink equipment.

AFT Pharmaceuticals delivered a 22% revenue jump in FY26 to NZD 254.7 million, surpassing profit guidance and expanding its footprint to 87 countries. The company is advancing multiple R&D projects, including a pivotal Phase III injectable iron trial, while targeting over NZD 300 million in revenue for FY27.

ClearVue Technologies has secured A$6 million through a $5 million institutional placement and a fully underwritten $1 million Share Purchase Plan, aiming to bolster its balance sheet and fund international expansion and product development.

Memphasys has secured $1.2 million through a share placement to support the global expansion and manufacturing scale-up of its Felix™ sperm selection system. The company also extended a major convertible note, reinforcing financial flexibility amid growing international contracts.

icetana AI has expanded its strategic partnership with SoftBank Robotics Group by signing a distribution agreement with SoftBank Robotics America, marking its entry into one of the world's largest security technology markets.